JPRN-UMIN000010549已完成未知
Phase II study of Temozolomide monotheraphy in patients with first line treatment-refractory neuroendocrine carcinoma - Second line treatment of Temozolomide in neuroendocrine carcinoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 13
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 76years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •cerebral vascular disease untreatment bone fracture uncontrolable ulcer tendency of bleeding another major carcinoma cerebral vascular disease active infection HBV hepatitis or carrier uncontrolable hypertension intestinal pneumonia past history of intake aboutimmunosuppressive agents tubeluclosis cardiac disease pregnancy
研究者
相似试验
进行中（未招募）
不适用
Phase 2 single-arm studies of Temozolomide in combination with Topotecan in refractory or relapsing Neuroblastoma and Other pediatric solid tumours. - ITCC 013 - TOTEM2euroblastoma and Other pediatric solid tumours.MedDRA version: 9.1Level: LLTClassification code 10066595Term: Neuroblastoma recurrentEUCTR2008-001436-12-ATInstitut Gustave Roussy93
进行中（未招募）
不适用
Phase 2 single-arm studies of Temozolomide in combination with Topotecan in refractory or relapsing Neuroblastoma and Other pediatric solid tumours. - ITCC 013 - TOTEM2euroblastoma and Other pediatric solid tumours.MedDRA version: 9.1Level: LLTClassification code 10066595Term: Neuroblastoma recurrentEUCTR2008-001436-12-FRInstitut Gustave Roussy125
进行中（未招募）
不适用
Phase 2 single-arm studies of Temozolomide in combination with Topotecan in refractory or relapsing Neuroblastoma and Other pediatric solid tumours. - ITCC 013 - TOTEM2EUCTR2008-001436-12-NLInstitut Gustave Roussy93
招募中
2 期
Temozolomide as monotherapy for elderly and temozolomide sensitive glioblastomaglioblastomaJPRN-jRCTs031200438Tateishi Kensuke5
进行中（未招募）
1 期
A Phase 2 Study of Temozolomide (SCH 52365) in Subjects With Advanced Aerodigestive Tract Cancers Selected for Methylation of O6-Methyl-Guanine-DNA Methyltransferase (MGMT) Promoter. - P04273Advanced Aerodigestive Tract Cancers (Colorectal Cancer (CRC), Non Small Cell Lung Cancer (NSCLC), Head & Neck (H & N), Esophageal Cancer).MedDRA version: 9.1 Level: LLT Classification code 10028980 Term: NeoplasmEUCTR2006-003169-15-ITSCHERING-PLOUGH160